Navigation Links
Chimerix to Present at Upcoming Investor Conferences
Date:6/2/2010

RESEARCH TRIANGLE PARK, N.C., June 2 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced today that Kenneth I. Moch, President and Chief Executive Officer, will present at two upcoming investor conferences:  the 9th Annual Needham Healthcare Conference, 9:00 AM ET, June 9, 2010, and the Jefferies 2010 Global Life Sciences Conference, 12:45 PM ET, June 11, 2010. The conferences are being held in New York City.

Mr. Moch will provide a corporate overview, including an update on the company's clinical-stage candidates, CMX001 and CMX157.  CMX001 is an orally-available, broad-spectrum antiviral being developed for the treatment of dsDNA viral infections in immunocompromised patients.  The compound is in Phase 1 and 2 clinical trials for the treatment of cytomegalovirus and BK virus.  CMX157, a novel lipid conjugate of the drug tenofovir, was created to improve upon the efficacy and safety of the prodrug Viread®, the leading nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV patients.  CMX157, which is in Phase 1 clinical trials, is being developed for its potential to reduce systemic toxicity and enable the development of one-pill once-a-day fixed dose anti-HIV combinations.

About Chimerix

Chimerix is developing antiviral therapeutics to treat life-threatening diseases.  Led by a world-class antiviral drug development team, Chimerix is advancing programs to address cytomegalovirus (CMV), BK virus, adenovirus, smallpox, human immunodeficiency virus (HIV), hepatitis C virus (HCV), respi
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Chimerix Initiates Phase 1 Study of CMX157
2. Chimerix Names George Painter, Ph.D., Chairman of the Board and Chief Scientific Officer; Appoints Kenneth I. Moch President and Chief Executive Officer
3. Chimerix Names Wendy Painter, M.D., M.P.H., as Chief Medical Officer
4. Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
5. Chimerix Joins International Network of Organizations to Cure Malaria
6. Chimerix Completes Phase I Study and Initiates a Phase II Multi-dose Clinical Trial for CMX001
7. Merial to Screen Chimerix Chemical Library for Animal Health Drug Leads
8. Chimerix Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer
9. NeoGenomics to Present at Noble Financials 6th Annual Equity Conference on Monday, June 7th
10. China-Biotics to Present at Bank of America Merrill Lynch Healthcare Event on June 22
11. Merrimack Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...
(Date:7/24/2014)... 24, 2014  Now available is a stem cell ... Regenerative Therapies , located in Guadalajara, Mexico ... people a new health option: stem cell therapies ... countless patients suffer from joint and muscle injuries due ... tears, torn rotator cuff, tennis elbow, and knee injuries. ...
(Date:7/24/2014)... worldwide rely on sophisticated equipment, trained personnel, and ... areas against terrorist attacks. A revolutionary new electronic ... make their job much easier. , The groundbreaking ... Tel Aviv University ,s School of Chemistry and ... the Herzliya company Tracense, picks up the scent ...
(Date:7/24/2014)... at the University of Delaware, is known worldwide ... engineering, environmental sustainability and electronics. , His early ... a well-defined, crystalline structure. At the atomic scale, ... zeolites can separate molecules with size differences of ... a nanometer), making them useful to the chemical ...
Breaking Biology Technology:Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Nano-sized chip 'sniffs out' explosives far better than trained dogs 2University of Delaware researcher describes new approach for creating organic zeolites 2
... ABC,s Dancing with the Stars champion Drew Lachey has teamed ... launch the first national online video contest to increase ... The contest invites people to ... that help them stay active and healthy., ...
... EXTON, Pa., May 6 BioTrends Research Group,Inc. ... comprehensive insight into the management of,renal anemia and ... and Dialysis. These reports provide information from 105 ... -- data were collected,through an online survey fielded ...
... May 6 MedImmune today announced that,it ... the company,s expanded product,pipeline in the United ... core scientific,research that underpins this development. Jacqueline ... development team leadership; Lorin,Roskos, Ph.D. has been ...
Cached Biology Technology:Dancing With the Stars' Drew Lachey and Novo Nordisk Launch Dancin' to Change Diabetes National Video Contest 2BioTrends Releases Two Publications - TreatmentTrends(TM): Nephrologists and TreatmentTrends(TM): Renal Dietitians - Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Two Publications - TreatmentTrends(TM): Nephrologists and TreatmentTrends(TM): Renal Dietitians - Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments 2MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments 3
(Date:7/28/2014)... research has identified areas of the Earth that are ... change. , Europe is particularly vulnerable, as it has ... per cent, of any continent in ,refugia, areas ... environmental conditions remain relatively constant during times of great ... are mostly in Scandinavia and Scotland. , The ...
(Date:7/28/2014)... He calls himself the bug hunter, but the ... only be found and identified with special methods and ... Kansas State Veterinary Diagnostic Laboratory at Kansas State University, ... porcine enterovirus G, which is an important find in ... in cells, but didn,t know what it was," Hause ...
(Date:7/28/2014)... study found that 73 percent of adult survivors of ... metabolic syndrome and related health problems by failing to ... current issue of the journal Cancer . , ... childhood cancer in the study had metabolic syndrome, an ... pressure, abdominal obesity, elevated triglyceride and other abnormalities that ...
Breaking Biology News(10 mins):Study finds Europe's habitat and wildlife is vulnerable to climate change 2Researcher using next-generation sequencing to rapidly identify pathogens 2Researcher using next-generation sequencing to rapidly identify pathogens 3Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 2Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 3
... under the microscope: the relation between biology and genetics ... the main themes of the International Workshop on the ... Bologna, May 20 to 22, with leading scientists currently ... explain their recent findings to the audience. The meeting ...
... technology, researchers are getting a better understanding of a physiological ... provide quick access to a lot of oxygen, can survive ... so efficient that resting insects stop taking in air as ... Hetz of Humboldt University in Berlin, Germany. This allows them ...
... growth of blood vessels critical to the spread of ... discovered by researchers from the U.S. Department of Energy's ... a beamline at the Advanced Photon Source. , Growing ... angiogenesis ?is important in growth, development and wound healing. ...
Cached Biology News:Music genes and musical geniuses 2Breathing easy: When it comes to oxygen, a bug's life is full of it 2Breathing easy: When it comes to oxygen, a bug's life is full of it 3Breathing easy: When it comes to oxygen, a bug's life is full of it 4Cancer cells forming blood vessels send their copper to the edge 2Cancer cells forming blood vessels send their copper to the edge 3